Measles: the legacy of low vaccine coverage
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Measles is among the most infectious diseases of humans. Prior to the introduction of vaccination, virtually every child in the UK caught measles during two-yearly epidemics that each involved up to 700 000 reported cases. The illness presents with fever, coryza, cough and conjunctivitis before progressing to the classic rash after 2–4 days.1 Complications are more common in the very young and in adults and include otitis media, pneumonia, diarrhoea, keratitis and encephalitis. Although measles still kills around 150 000 children per year worldwide, in industrialised countries, case-fatality ratios are low with around one death for every 2000–5000 reported cases.1 ,2 The infection is most serious for individuals who are immunosuppressed, who may experience diffuse progressive pneumonitis or a delayed form of encephalitis, both associated with a high risk of death. For example, between 1974 and 1984, nearly one-third of deaths in British children in remission from leukaemia were measles related.3 The WHO aims to achieve measles elimination in at least five WHO regions by 2020, with the elimination target for the European region set at 2015 . 4 In the UK, measles vaccine was first introduced in 1968 for children in the second year of life. Although a single dose of measles vaccine provides between 90 and 95% protection,5–7 coverage remained low and measles continued to cause regular epidemics right up until the late 1980s. In 1988, the year that measles-mumps-rubella (MMR) vaccine was introduced, around 86 000 cases and 16 deaths were reported in England and Wales.8 Following the introduction of MMR, coverage improved to 92% and was sustained at this high level throughout the early 1990s. In November 1994, to prevent a predicted epidemic of measles amongst older children, combined measles-rubella vaccine was offered to all school children aged 5–16 years in a national vaccination campaign. …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wakefield, A., Murch, S., Anthony, A., Linnell, J., Casson, D., Malik, M., Berelowitz, M., Dhillon, A., Thomson, M., Harvey, P., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11096-0 · Cited by 3,006
RetractedAutism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association
Taylor, B., Miller, E., Farrington, C., Petropoulos, M.-C., Favot-Mayaud, I., Li, J., & Waight, P. A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01239-8 · Cited by 753
Cited by
Sumner, P., Vivian-Griffiths, S., Boivin, J., Williams, A., Venetis, C. A., Davies, A., Ogden, J., Whelan, L., Hughes, B., Dalton, B., et al. (2014) · BMJ · doi:10.1136/bmj.g7015 · Cited by 489
Vaccine hesitancy, refusal and access barriers: The need for clarity in terminology
Bedford, H., Attwell, K., Danchin, M., Marshall, H., Corben, P., & Leask, J. (2018) · Vaccine · doi:10.1016/j.vaccine.2017.08.004 · Cited by 321
Exaggerations and Caveats in Press Releases and Health-Related Science News
Sumner, P., Vivian-Griffiths, S., Boivin, J., Williams, A., Bott, L., Adams, R., Venetis, C. A., Whelan, L., Hughes, B., & Chambers, C. D. (2016) · PLOS ONE · doi:10.1371/journal.pone.0168217 · Cited by 155
Claims of causality in health news: a randomised trial
Adams, R. C., Challenger, A., Bratton, L., Boivin, J., Bott, L., Powell, G., Williams, A., Chambers, C. D., & Sumner, P. (2019) · BMC Medicine · doi:10.1186/s12916-019-1324-7 · Cited by 69
“vaccines, statins) [10, 11], and ‘spin’ in news has been experimentally shown to influence clinicians’ interpretation [33].”
Background
Metadata
- Authors
- Ramsay, M. E.
- Venue
- Archives of Disease in Childhood
- Publisher
- BMJ
- Published
- 2013-07-29
- Volume
- 98
- Issue
- 10
- Pages
- 752-754
- ISSN
- 0003-9888 (ISSN-L)
- 1468-2044
- OpenAlex
- W2148480108
- Cited by
- 40
- References
- 2
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Measles: the legacy of low vaccine coverage. https://app.cochat.ai/papers/10.1136/archdischild-2013-304292
- The paper
- Ramsay, M. E. (2013). Measles: the legacy of low vaccine coverage. Archives of Disease in Childhood. https://doi.org/10.1136/archdischild-2013-304292
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.